IDEXX Labs Earnings, Revenue Beat in Q3

In this article:
IDEXX Labs Earnings, Revenue Beat in Q3
IDEXX Labs Earnings, Revenue Beat in Q3

Investing.com - IDEXX Labs reported third quarter earnings that beat analysts' expectations on Thursday and revenue that topped forecasts.

The firm reported earnings per share of $1.24 on revenue of $605.3M. Analysts polled by Investing.com expected EPS of $1.14 on revenue of $597.07M. That compared to EPS of $1.05 on revenue of $545.45M in the same period a year earlier. The company had reported EPS of $1.43 on revenue of $620.1M in the previous quarter.

IDEXX Labs follows other major Healthcare sector earnings this month

On October 15, J&J reported third quarter EPS of $2.12 on revenue of $20.73B, compared to forecasts of EPS of $2.01 on revenue of $20.08B.

Merck&Co earnings beat analysts' expectations on Tuesday, with third quarter EPS of $1.51 on revenue of $12.4B. Investing.com analysts expected EPS of $1.24 on revenue of $11.65B

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Related Articles

American Tower Earnings, Revenue Beat in Q3

Bristol-Myers Squibb Earnings, Revenue Beat in Q3

Wealth gap among retired Americans worsens despite a growing economy

Advertisement